EICHORCondition: Arthritis, Juvenile Rheumatoid · Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
This multi-center observational Registry will collect long-term safety data on patients treated with celecoxib or non-selective nonsteroidal anti-inflammatory drugs (nsNSAIDs) as used in clinical practice for the treatment of Juvenile Idiopathic Arthritis (JIA).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Age at least 2 years but less than 18 years; JIA of any of the following subtypes: oligoarthritis, polyarthritis, or stable systemic disease; * new treatment (started not more than 6 months prior) with one NSAID (celecoxib or nsNSAID). Exclusion Criteria: * Patients with the following JIA subtypes: active systemic disease, psoriatic Arthritis, enthesitis-related Arthritis, or undifferentiated arthritis; * Patients with Reiter's syndrome; patients unlikely to complete 2 years of follow up; * Patients who need to use multiple NSAIDs at the same time.
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Pfizer Investigational Site | Phoenix, Arizona, United States | — |
| Pfizer Investigational Site | Little Rock, Arkansas, United States | — |
| Pfizer Investigational Site | Washington D.C., District of Columbia, United States | — |
| Pfizer Investigational Site | Arlington Heights, Illinois, United States | — |
| Pfizer Investigational Site | Chicago, Illinois, United States | — |
| Pfizer Investigational Site | Glenview, Illinois, United States | — |
| Pfizer Investigational Site | New Lenox, Illinois, United States | — |
| Pfizer Investigational Site | Westchester, Illinois, United States | — |
| Pfizer Investigational Site | Omaha, Nebraska, United States | — |
| Pfizer Investigational Site | Hackensack, New Jersey, United States | — |
| Pfizer Investigational Site | Livingston, New Jersey, United States | — |
| Pfizer Investigational Site | Brooklyn, New York, United States | — |
+ 15 more locations — full list on the registry record.
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00688545